Ascendis Pharma A/S
ASND | NASDAQ
$250.89
-$0.38 (-0.15%)
Nov 2, 2026, 11:48 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 615.78M | 559.54M | 392.16M | 444.77M | 446.27M | 584.52M |
Short-Term Investments | n/a | n/a | 7.28M | 290.69M | 235.8M | 134.28M |
Long-Term Investments | 43.38M | 13.58M | 5.69M | 30.42M | 145.91M | 124.46M |
Other Long-Term Assets | n/a | 2.32M | 2.13M | 1.92M | 1.81M | 1.38M |
Receivables | 157.63M | 166.28M | 35.87M | 11.91M | 2.2M | 387K |
Inventory | 301.4M | 295.61M | 208.93M | 130.67M | 75.41M | n/a |
Other Current Assets | n/a | 11.16M | 19.9M | 13.72M | 20.99M | 6.96M |
Total Current Assets | 1.11B | 1.06B | 702.72M | 923.47M | 805.89M | 740.13M |
Property-Plant & Equipment | 146.42M | 98.71M | 110.63M | 129.1M | 126.05M | 108.11M |
Goodwill & Intangibles | 3.71M | 4.03M | 4.42M | 4.83M | 5.27M | 5.72M |
Total Long-Term Assets | 193.5M | 118.63M | 122.87M | 166.27M | 279.04M | 239.66M |
Total Assets | 1.3B | 1.18B | 825.59M | 1.09B | 1.08B | 979.79M |
Account Payables | 90.62M | 96.39M | 94.57M | 101.03M | 59.42M | 21.9M |
Deferred Revenue | 4.94M | 936K | 1.18M | n/a | 2.6M | 363K |
Short-Term Debt | 486.32M | 491.54M | 421.27M | 412.98M | 7M | n/a |
Other Current Liabilities | 480.63M | 317.78M | 203.02M | 183.49M | 24.15M | 23.38M |
Total Current Liabilities | 1.07B | 907.86M | 736.51M | 716.78M | 100.36M | 52.8M |
Long-Term Debt | 385.09M | 365.08M | 223M | 95.4M | 97.97M | n/a |
Other Long-Term Liabilities | n/a | n/a | -84.62M | -95.4M | -97.97M | 3.16M |
Total Long-Term Liabilities | 395.83M | 377.34M | 234.78M | 109.61M | 100.93M | 88.28M |
Total Liabilities | 1.46B | 1.29B | 971.28M | 826.39M | 201.29M | 141.08M |
Total Debt | 871.41M | 856.62M | 743.06M | 617.57M | 209.92M | 91.98M |
Book Value | -162.75M | -105.71M | -145.7M | 263.35M | 883.64M | 838.71M |
Book Value Per Share | -2.69 | -1.83 | -2.59 | 4.70 | 16.13 | 16.57 |
Common Stock | 8.32M | 8.15M | 7.75M | 7.68M | 7.65M | 7.22M |
Retained Earnings | -2.7B | -2.56B | -2.28B | -1.86B | -1.24B | -1.03B |
Comprehensive Income | -1.75M | 1.78M | 721K | 3.45M | 3.78M | 133.02M |
Shareholders Equity | -162.75M | -105.71M | -145.7M | 263.35M | 883.64M | 838.71M |
Total Investments | 43.38M | 13.58M | 12.96M | 321.11M | 381.7M | 258.73M |
Add to Watchlist
Select watchlists to add or remove ASND